Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Coagulant Therapeutics presents preclinical data on CT-001

July 18, 2022

Novel hemophilia A murine model to test IdeS proteinase efficacy

July 18, 2022

CM-352 reduces MMP10-driven fibrinolysis in rivaroxaban-associated ICH

July 15, 2022

FVIII-QQ gene transfer therapy shows advantage for treating hemophilia A

July 14, 2022

Limitations of certain mouse models for sickle cell research highlighted

July 8, 2022

New coagulation factor XIa inhibitors discovered at Shanghai Leadingtac Pharmaceutical

July 7, 2022

KalVista Pharmaceuticals patents FXIIa inhibitors

June 29, 2022

Merck & Co. identifies new FXIa and/or KLKB1 inhibitors

June 16, 2022

EHA 2022 presentations describe sickle cell disease headway and headwinds

June 14, 2022

At EHA 2022, insights into multiple reasons for marrow failure

June 13, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
mRNA flu vaccine can activate broad germinal center response
BioWorld
On the eve of the June 17 Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting, which will discuss Moderna Inc.’s mRNA-1010, researchers...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...